section name header

Pronunciation

VYE-ta-min A

Classifications

Therapeutic Classification: vitamins (fat-soluble)

Indications

REMS


Action

  • Serves as a cofactor in many biochemical processes.
  • Necessary for growth, bone development, vision, reproduction, integrity of mucosal and epithelial surfaces, and formation of visual pigment.
Therapeutic effects:
  • Resolution of deficiency signs.
  • Prevention of deficiency.

Pharmacokinetics

Absorption: GI absorption requires bile acids, fat, lipase, and protein. Aqueous preparations are absorbed more readily than emulsions.

Distribution: Stored primarily in the liver (2-yr supply); small amounts stored in kidneys and lungs. Does not cross the placenta but enters breast milk.

Metabolism/Excretion: Mostly metabolized by the liver.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown
IMunknownunknownunknown





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Misc: hypervitaminosis A syndrome

Interactions

Drug-drug:

Route/Dosage

Kwashiorkor

Xerophthalmia

Parenteral dosing

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Aquasol A